Noticias de XTLB_US

Noticias del mercado

Últimas noticias sobre XTLB_US — 96 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: XTLB_US ✕ 96 resultados
18/04/2026 XTLB_US — haiphong.gov.vn
XTL (XTLB) Stock: Is It Overvalued (Modest Decline) 2026-04-18 - Top Picks
18/04/2026 XTLB_US — Newser
XTL (XTLB) Stock: Is It Overvalued (Modest Decline) 2026-04-18 - Factor Timing
18/04/2026 XTLB_US — newser.com
XTL (XTLB) Stock: Is It Overvalued (Modest Decline) 2026-04-18 - Investment Signal Network
18/04/2026 XTLB_US — The Legal Advocate
XTL (XTLB) Stock: Is It Overvalued (Modest Decline) 2026-04-18 - Extension Target
18/04/2026 XTLB_US — Newser
XTL (XTLB) Stock: Is It Overvalued (Modest Decline) 2026-04-18 - MFI Oversold
18/04/2026 XTLB_US — thelegaladvocate.com
XTL (XTLB) Stock: Is It Overvalued (Modest Decline) 2026-04-18 - Put Flow Alert
18/04/2026 XTLB_US — Newser
XTL (XTLB) Stock: Is It Overvalued (Modest Decline) 2026-04-18 - Trading Ideas
18/04/2026 XTLB_US — thelegaladvocate.com
XTL (XTLB) Stock: Is It Overvalued (Modest Decline) 2026-04-18 - Passive Flow
18/04/2026 XTLB_US — Newser
XTL (XTLB) Stock: Is It Overvalued (Modest Decline) 2026-04-18 - Open Stock Picks
18/04/2026 XTLB_US — newsline.com
XTL (XTLB) Stock: Is It Overvalued (Modest Decline) 2026-04-18 - IV Rank
18/04/2026 XTLB_US — thelegaladvocate.com
XTL (XTLB) Stock: Is It Overvalued (Modest Decline) 2026-04-18 - Earnings Miss Risk
16/04/2026 XTLB_US — newser.com
XTLB XTL Biopharmaceuticals Ltd. American Depositary Shares rises 4.2 percent following release of its 2025 first quarter earnings report. - Forward EPS
16/04/2026 XTLB_US — Newser
XTLB XTL Biopharmaceuticals Ltd. American Depositary Shares rises 4.2 percent following release of its 2025 first quarter earnings report. - Community Breakout Alerts
16/04/2026 XTLB_US — newsline.com
XTLB XTL Biopharmaceuticals Ltd. American Depositary Shares rises 4.2 percent following release of its 2025 first quarter earnings report. - Gross Profit Margin
16/04/2026 XTLB_US — Newser
XTLB XTL Biopharmaceuticals Ltd. American Depositary Shares rises 4.2 percent following release of its 2025 first quarter earnings report. - Financial Health
16/04/2026 XTLB_US — The Legal Advocate
XTLB XTL Biopharmaceuticals Ltd. American Depositary Shares rises 4.2 percent following release of its 2025 first quarter earnings report. - Next Quarter Guidance
16/04/2026 XTLB_US — Newser
XTLB XTL Biopharmaceuticals Ltd. American Depositary Shares rises 4.2 percent following release of its 2025 first quarter earnings report. - Dividend Growth Rate
16/04/2026 XTLB_US — Newser
XTLB XTL Biopharmaceuticals Ltd. American Depositary Shares rises 4.2 percent following release of its 2025 first quarter earnings report. - Next Quarter Guidance
16/04/2026 XTLB_US — The Legal Advocate
XTLB XTL Biopharmaceuticals Ltd. American Depositary Shares rises 4.2 percent following release of its 2025 first quarter earnings report. - Earnings Quality Score
08/04/2026 XTLB_US — Newser
What valuation model applies to XTL (XTLB) Stock | Price at $2.40, Down 1.84% - Trade Ideas

Página 4 de 5

keyboard_arrow_up